Saccomano Nicholas A (CIK 1609284) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-23). Recent activity: Sell OKUR (87 shares), Sell OKUR (86 shares), Sell OKUR (86 shares), Sell OKUR (87 shares), Sell OKUR (88 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 87 | $259 |
| 2026-06-24 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 86 | $378 |
| 2026-03-24 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 86 | $358 |
| 2025-12-23 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 87 | $258 |
| 2025-09-24 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 88 | $231 |
| 2025-06-25 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 88 | $209 |
| 2025-04-08 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 358 | $1,192 |
| 2025-04-08 | OnKure Therapeutics, Inc. (OKUR) | President and CEO | Sell | 516 | $1,378 |
来源：SEC Form 4 申报文件 · 截至 2026-09-23